Subscribe to email notification of Alerts, Advisories and Updates posted to this page by emailing mricci@wakegov.com or by calling 919-250-4462.
*2019 Novel Coronavirus (2019-nCoV)*
FDA Recalls, Market Withdrawals and Safety Alerts
There are no alerts as of 7-9-20.
7-6-20 NC Division of Public Health
This memo updates previous guidance shared on June 9, 2020. It is intended to provide the latest information to
all North Carolina clinicians and laboratory staff regarding the Coronavirus Disease 2019 (COVID-19). Please read
thoroughly as there are several updates, including:
6-23-20 NC Division of Public Health
This memo provides guidance on antigen test results and diagnosis of SARS-CoV-2.
6-9-20 NC Division of Public Health
This memo updates previous guidance shared on May 15, 2020. It is intended to provide the latest information to all North Carolina clinicians and laboratory staff regarding the Coronavirus Disease 2019 (COVID-19). Please read thoroughly as there are several updates, including:
- Updated laboratory testing guidance
- Updated resources on testing sites, PPE, and specimen collection supplies
5-20-20 NC Division of Public Health
Call for Cases: Clinician-suspected SARS-CoV-2 reinfection among COVID-19 cases
This memo is intended to provide information and request reporting of clinician-suspected SARS-CoV-2 reinfection among COVID-19 cases.
5-16-20 Wake County Human Services Division of Public Health
This memo addresses questions being asked by the public and patients about COVID-19 antibody testing and immunity.
5-15-20 NC Division of Public Health
This memo updates previous guidance shared on April 20, 2020. It is intended to provide the latest information to all North Carolina clinicians and laboratory staff regarding the Coronavirus Disease 2019 (COVID-19). Please read thoroughly as there are several updates, including:
• Updated laboratory testing guidance
• Updated criteria for submission of specimens to the North Carolina State
Laboratory of Public Health
5-14-20 Centers for Disease Control and Prevention (CDC)
CDC Health Advisory:
Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19)
The Centers for Disease Control and Prevention (CDC) is providing
1) background information on several cases of a recently reported multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19); and
2) a case definition for this syndrome. CDC recommends healthcare providers report any patient who meets the case definition to local, state, and territorial health departments to enhance knowledge of risk factors, pathogenesis, clinical course, and treatment of this syndrome.
5-14-20 NC Division of Public Health
This memo is intended to provide information regarding identification and reporting of a pediatric multisystem inflammatory syndrome potentially linked to COVID-19.
4-20-20 NC Division of Public Health
Coronavirus Disease 2019
(replaces version dated March 29, 2020)
This memo, intended to update all North Carolina clinicians and laboratory staff regarding COVID-19, includes the following updates:
- Updated laboratory testing guidance
- Updated criteria for submission of specimens to the North Carolina State Laboratory of Public Health
- Replacement of information that is not North Carolina-specific with links to relevant CDC guidance
4-13-20 NC Division of Public Health, Epi/CD/TB Control
This memo describes, in order to maintain social distancing, groups for whom the NC Tuberculosis Control Program recommends deferred baseline TB screening.
4-9-20 NC Division of Public Health
NC EDSS COVID-19 Reporting From --Part 2
3-29-20 NC Division of Public Health
Coronavirus Disease 2019
(replaces version dated March 23, 2020)
This memo, for all NC clinicians and laboratory staff, includes the following updates regarding COVID-19:
- Updated criteria for submission of specimens to the North Carolina State Laboratory of Public Health
- Providers no longer asked to fill out Persons Under Investigations forms for patients tested for COVID-19
- Requirement for reporting of COVID-19 deaths
3-16-2020 NC Division of Public Health
Coronavirus Disease 2019
This memo, intended to provide the latest COVID-19 information to all NC clinicians and laboratory staff, includes the following updates:
- Emphasize commercial laboratory testing availability
- Updated guidance for discontinuation of isolation for Persons Under Investigation
- Clarifications to infection prevention and control guidance and
- Updated procedures for testing approval from local health departments
3-13-2020 NC Division of Public Health
Coronavirus Disease 2019
This memo intends to provide the latest COVID-19 information to all NC clinicians and laboratory staff. This memo includes the following updates:
- Updated infection prevention and control guidance
- Updated specimen collection guidance and
- Guidance provided to CLIA high complexity testing laboratories that are implementing COVID 19 testing.
3-10-20 NC Division of Public Health
This memo, intended to provide the latest information to all NC clinicians and laboratory staff regarding COVID-19, includes the following updates:
- Updated criteria to guide evaluation for patients under investigation for COVID-19
- Updated guidance for discontinuation of isolation for Persons Under Investigation
- Updates specimen collection instructions, specifically to include NP and OP swabs in a single tube and
- Storage of any unused portions of NCSLPH COVID-19 specimen collection kits for future use
2-28-20 NC Division of Public Health
This memo, intended to provide the latest information to all NC clinicians and laboratory staff regarding the Coronavirus Disease 2019 (COVID-19), includes the following updates:
- Updated criteria to guide evaluation for patients under investigation for COVID-19
- Updated specimen collection and laboratory testing guidance for suspected cases of COVID -19
2-7-20 Wake County Human Services Public Health Division
On February 3, the NC Division of Public Health issued a new memo with the following updates regarding the 2019 Novel Coronavirus (2019-nCoV):
- Updated criteria to guide evaluation for patients under investigation for 2019-nCoV
- A new requirement for NC physicians and laboratories to report all suspected cases of 2019-nCoV
- Specimen collection and laboratory testing guidance for suspected cases of 2019-nCoV.
As information about 2019-nCoV is evolving quickly, healthcare providers are encouraged to visit the following sites often for the most up to date information and resources:
Additionally, NCDPH has established:
- a call line for the public to address general questions about coronavirus: 1-866-462-3821
- an email address for healthcare providers to address non-urgent questions: ncresponse@DHHS.nc.gov
Healthcare providers can also sign up for email notification of Public Health alerts, advisories and updates by contacting mricci@wakegov.com or calling 919-250-4462.
1-24-2020 NC Department of Health and Human Services
This memo provides the latest information and guidance to all NC clinicians regarding the 2019 Novel Coronavirus in Wuhan, China, including case investigation, specimen testing requirements and infection control.
1-22-2020 Centers for Disease Control and Prevention (CDC)
This health alert from the CDC is to update and provide interim guidance on the outbreak of 2019 Novel Coronavirus (2019-nCoV) in Wuhan, China. This update provides guidance for evaluation of patients under investigation for 2019-nCoV, prevention and infection control guidance, including the addition of an eye protection recommendation and additional information of specimen collection.